The high-affinity receptor for immunoglobulin E: a target for therapy of allergic diseases. 1991

J P Kinet, and U Blank, and A Brini, and M H Jouvin, and H Küster, and O Mejan, and C Ra
Molecular Allergy and Immunology Section, National Institute of Allergy and Infectious Diseases, Rockville, Md.

The high-affinity receptor for IgE (Fc epsilon RI) on mast cells and basophils is a tetrameric complex, alpha beta gamma 2. Here we summarize the latest developments on the structure and function of this receptor. By genetic transfer, we have engineered a cell line secreting substantial amounts of a peptide containing exclusively the extracellular domain of the alpha-subunit. This domain by itself is sufficient to mediate high-affinity binding of IgE. Glycosylation and the presence of the other subunits are not necessary for the binding function. The gamma-subunit of Fc epsilon RI is part of other receptors such as Fc gamma RIII and the T cell receptor, and therefore is likely to play an important although still undefined functional role. A detailed knowledge of how the receptor interacts with IgE and induces cellular degranulation may lead to the design of new therapeutic approaches to allergic diseases. The potential strategies are discussed.

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000944 Antigens, Differentiation, B-Lymphocyte Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumors of B-cell origin. Antigens, Differentiation, B-Cell,B-Cell Differentiation Antigens,B-Lymphocyte Differentiation Antigens,Blast-2 Antigen, B-Cell,Differentiation Antigens, B-Cell,Differentiation Antigens, B-Lymphocyte,Leu Antigens, B-Lymphocyte,Plasma Cell Antigens PC-1,Antigens, Differentiation, B Lymphocyte,Antigens, Plasma Cell, PC-1,B-Cell Blast-2 Antigen,Antigen, B-Cell Blast-2,Antigens, B-Cell Differentiation,Antigens, B-Lymphocyte Differentiation,Antigens, B-Lymphocyte Leu,B Cell Blast 2 Antigen,B Cell Differentiation Antigens,B Lymphocyte Differentiation Antigens,B-Lymphocyte Leu Antigens,Blast 2 Antigen, B Cell,Differentiation Antigens, B Cell,Differentiation Antigens, B Lymphocyte,Leu Antigens, B Lymphocyte,Plasma Cell Antigens PC 1
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D017455 Receptors, IgE Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI). Antigens, CD23,CD23 Antigens,Fc Receptors, epsilon,Fc epsilon Receptor,Fc epsilon Receptors,IgE Receptor,IgE Receptors,Receptors, Fc epsilon,epsilon Fc Receptor,epsilon Fc Receptors,CD 23 Antigens,CD23 Antigen,Fc epsilon RI,Fc epsilon RII,Immunoglobulin E Receptor,Antigen, CD23,Antigens, CD 23,Fc Receptor, epsilon,Receptor, Fc epsilon,Receptor, IgE,Receptor, Immunoglobulin E,Receptor, epsilon Fc,Receptors, epsilon Fc,epsilon RI, Fc,epsilon RII, Fc,epsilon Receptor, Fc,epsilon Receptors, Fc

Related Publications

J P Kinet, and U Blank, and A Brini, and M H Jouvin, and H Küster, and O Mejan, and C Ra
May 2016, European journal of pharmacology,
J P Kinet, and U Blank, and A Brini, and M H Jouvin, and H Küster, and O Mejan, and C Ra
January 1994, Chemical immunology,
J P Kinet, and U Blank, and A Brini, and M H Jouvin, and H Küster, and O Mejan, and C Ra
July 1998, International archives of allergy and immunology,
J P Kinet, and U Blank, and A Brini, and M H Jouvin, and H Küster, and O Mejan, and C Ra
January 1986, Annual review of immunology,
J P Kinet, and U Blank, and A Brini, and M H Jouvin, and H Küster, and O Mejan, and C Ra
January 1989, Sub-cellular biochemistry,
J P Kinet, and U Blank, and A Brini, and M H Jouvin, and H Küster, and O Mejan, and C Ra
October 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
J P Kinet, and U Blank, and A Brini, and M H Jouvin, and H Küster, and O Mejan, and C Ra
September 1988, JAMA,
J P Kinet, and U Blank, and A Brini, and M H Jouvin, and H Küster, and O Mejan, and C Ra
February 1994, ImmunoMethods,
J P Kinet, and U Blank, and A Brini, and M H Jouvin, and H Küster, and O Mejan, and C Ra
April 2002, Biochemical and biophysical research communications,
J P Kinet, and U Blank, and A Brini, and M H Jouvin, and H Küster, and O Mejan, and C Ra
February 1996, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!